Related Experiment Video
Updated: Jun 22, 2026

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
Alternative surgery for low grade thyroid malignancies
Kai-Yuan Hsiao1, Jenq-Yuh Ko, Yong-Tsung Hong
1Department of Otolaryngology, Zhongxing Branch, Taipei City Hospital, Taipei 100, Taiwan.
Summary
This study presents a simplified total thyroidectomy technique for well-differentiated thyroid cancer (WDTC). Avoiding initial identification of the recurrent laryngeal nerve (RLN) and parathyroid glands (PTGs) proved safe and effective.
Area of Science:
- Surgical Oncology
- Endocrine Surgery
Background:
- Traditional thyroidectomy requires initial localization of critical structures like the recurrent laryngeal nerve (RLN) and parathyroid glands (PTGs).
- Well-differentiated thyroid cancer (WDTC) often has low-grade malignancy, and the RLN's position can make initial identification challenging.
Purpose of the Study:
- To evaluate the safety and efficacy of total thyroidectomy for WDTC without initial identification of the RLN and PTGs.
- To assess complications and clinical outcomes of this modified surgical approach.
Main Methods:
- 33 patients with WDTC underwent total thyroidectomy along the capsule, with or without modified radical neck dissection, without pre-identifying the RLN and PTGs.
- Surgical technique involved cutting the isthmus, capsular vessels, and Berry's ligament from above, allowing identification of the RLN and PTGs during thyroid removal.
Main Results:
- Only one patient (3%) experienced transient vocal palsy.
- Six patients (18%) had incidental parathyroidectomy, leading to temporary hypocalcemia in two (6%) and permanent hypocalcemia in two (6%).
- One patient died of disease recurrence; others remained disease-free during follow-up until December 2007.
Conclusions:
- Total thyroidectomy for WDTC without initial identification of the RLN and PTGs is a feasible and safe alternative surgical method.
- This approach simplifies the procedure while maintaining acceptable oncological outcomes and managing potential complications.